{
  "DOI": "10.1007/s10689-017-0002-1",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-017-0002-1",
  "alternative-id": [
    "2"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "O’Shea",
      "given": "R.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Clarke",
      "given": "R.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Berkley",
      "given": "E.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Giffney",
      "given": "C.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Farrell",
      "given": "M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "O’Donovan",
      "given": "E.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gallagher",
      "given": "D. J.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2017,
        5,
        16
      ]
    ],
    "date-time": "2017-05-16T10:43:13Z",
    "timestamp": 1494931393000
  },
  "deposited": {
    "date-parts": [
      [
        2018,
        1,
        16
      ]
    ],
    "date-time": "2018-01-16T10:07:17Z",
    "timestamp": 1516097237000
  },
  "indexed": {
    "date-parts": [
      [
        2022,
        4,
        2
      ]
    ],
    "date-time": "2022-04-02T18:14:44Z",
    "timestamp": 1648923284478
  },
  "is-referenced-by-count": 7,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2017,
        5,
        16
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2018,
          1
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "unspecified",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2017,
            5,
            16
          ]
        ],
        "date-time": "2017-05-16T00:00:00Z",
        "timestamp": 1494892800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-017-0002-1/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-017-0002-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-017-0002-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "123-128",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2017,
        5,
        16
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2017,
        5,
        16
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2018,
        1
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1002/humu.22559",
      "author": "J Kamihara",
      "doi-asserted-by": "crossref",
      "first-page": "654",
      "issue": "6",
      "journal-title": "Hum Mutat",
      "key": "2_CR1",
      "unstructured": "Kamihara J, Rana HQ, Garber JE (2014) Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome. Hum Mutat 35(6):654–662",
      "volume": "35",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s40291-013-0020-0",
      "author": "AD Sorrell",
      "doi-asserted-by": "crossref",
      "first-page": "31",
      "issue": "1",
      "journal-title": "Mol Diagn Ther",
      "key": "2_CR2",
      "unstructured": "Sorrell AD, Espenschield CR, Culver JO, Weitzel JN (2013) TP53 testing and Li-Fraumeni syndrome: current status of clinical applications and future directions. Mol Diagn Ther 17(1):31–47",
      "volume": "17",
      "year": "2013"
    },
    {
      "DOI": "10.1200/JCO.2008.16.6959",
      "author": "KD Gonzalez",
      "doi-asserted-by": "crossref",
      "first-page": "1250",
      "issue": "8",
      "journal-title": "J Clin Oncol",
      "key": "2_CR3",
      "unstructured": "Gonzalez KD, Nolter KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, Han JH, Lowstuter K, Longmate J, Sommer SS, Weitzel JN (2009) Beyond Li Fraumeni syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol 27(8):1250–1256",
      "volume": "27",
      "year": "2009"
    },
    {
      "author": "FP Li",
      "first-page": "5358",
      "journal-title": "Cancer Res",
      "key": "2_CR4",
      "unstructured": "Li FP, Fraumeni JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358–5362",
      "volume": "48",
      "year": "1988"
    },
    {
      "author": "JM Birch",
      "first-page": "1298",
      "journal-title": "Cancer Res",
      "key": "2_CR5",
      "unstructured": "Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Jones PH, Binchy A, Crowther D, Craft AW, Eden OB, Evans DGR, Thompson E, Mann JR, Martin J, Mitchell ELD, Santibanez-Koref MF (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 54:1298–1304",
      "volume": "54",
      "year": "1994"
    },
    {
      "author": "RA Eeles",
      "first-page": "101",
      "journal-title": "Cancer Surviv",
      "key": "2_CR6",
      "unstructured": "Eeles RA (1995) Germline mutations in the TP53 gene. Cancer Surviv 25:101–124",
      "volume": "25",
      "year": "1995"
    },
    {
      "DOI": "10.1200/JCO.2009.22.7967",
      "author": "J Tinat",
      "doi-asserted-by": "crossref",
      "first-page": "108",
      "issue": "26",
      "journal-title": "J Clin Oncol",
      "key": "2_CR7",
      "unstructured": "Tinat J, Bougeard G, Baert-Desurmont S et al (2009) 2009 version of the Chompret criteria for Li Fraumeni syndrome. J Clin Oncol 27(26):108–109",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1200/JCO.2014.59.5728",
      "author": "G Bougeard",
      "doi-asserted-by": "crossref",
      "first-page": "2345",
      "journal-title": "J Clin Oncol",
      "key": "2_CR8",
      "unstructured": "Bougeard G, Renaux-Petel M, Flaman JM, Charbonnier C, Fermey P, Belotti M, Gauthier-Villars M, Stoppa-Lyonnet D, Consolino E, Brugieres L, Caron O, Benusiglio PR, Bressac de Paillerets B, Bonadona V, Bonaiti-Pellie C, Tinat J, Baert-Desurmont S, Frebourg T (2015) Revisiting Li-Fraumeni syndrome from TP53 carriers. J Clin Oncol 33:2345–2352",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1054/bjoc.2000.1167",
      "author": "A Chrompret",
      "doi-asserted-by": "crossref",
      "first-page": "1932",
      "journal-title": "Br J Cancer",
      "key": "2_CR9",
      "unstructured": "Chrompret A, Brugieres L, Ronsin M et al (2000) P53 germline mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer 82:1932–1937",
      "volume": "82",
      "year": "2000"
    },
    {
      "DOI": "10.1136/jmg.2008.058958",
      "author": "KD Gonzalez",
      "doi-asserted-by": "crossref",
      "first-page": "689",
      "journal-title": "J Med Genet",
      "key": "2_CR10",
      "unstructured": "Gonzalez KD, Buzin CH, Noltner KA, Gu D, Li W, Malkin D, Sommer SS (2009) High frequency of de novo mutations in Li-Fraumeni syndrome. J Med Genet 46:689–693",
      "volume": "46",
      "year": "2009"
    },
    {
      "author": "K Schneider",
      "key": "2_CR11",
      "unstructured": "Schneider K, Garber J (1993) Li-Fraumeni syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP (eds) GeneReviews, University of Washington, Seattle, Seattle",
      "volume-title": "GeneReviews",
      "year": "1993"
    },
    {
      "DOI": "10.1002/humu.10081",
      "author": "M Olivier",
      "doi-asserted-by": "crossref",
      "first-page": "607",
      "journal-title": "Hum Mutat",
      "key": "2_CR12",
      "unstructured": "Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P (2002) The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19:607–614",
      "volume": "19",
      "year": "2002"
    },
    {
      "DOI": "10.1002/humu.10185",
      "author": "JM Varley",
      "doi-asserted-by": "crossref",
      "first-page": "313",
      "journal-title": "Hum Mutat",
      "key": "2_CR13",
      "unstructured": "Varley JM (2003) Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat 21:313–320",
      "volume": "21",
      "year": "2003"
    },
    {
      "DOI": "10.1038/sj.bjc.6605606",
      "author": "DGR Evans",
      "doi-asserted-by": "crossref",
      "first-page": "1091",
      "journal-title": "Br J Cancer",
      "key": "2_CR14",
      "unstructured": "Evans DGR, Moran A, Hartley R, Dawson J, Bulman B, Knox F, Howell A, Lalloo F (2010) Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA I/BRCA2/TP53 status. Br J Cancer 102:1091–1098",
      "volume": "102",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10689-012-9557-z",
      "author": "JM McCuaig",
      "doi-asserted-by": "publisher",
      "journal-title": "Fam Cancer",
      "key": "2_CR15",
      "unstructured": "McCuaig JM, Armel SR, Novokmet A et al (2012) Routine TP53 testing for breast cancer under age 30: ready for prime time? Fam Cancer. doi:\n10.1007/s10689-012-9557-z",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.ejca.2005.11.032",
      "author": "F Lalloo",
      "doi-asserted-by": "crossref",
      "first-page": "1143",
      "journal-title": "Eur J Cancer",
      "key": "2_CR16",
      "unstructured": "Lalloo F, Varley J, Moran A, Ellis D, O’Dair L, Pharoah P, Antoniou A, Hartley R, Shenton A, Seal S, Bulman B, Howell A et al (2006) BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. Eur J Cancer 42:1143–1150",
      "volume": "42",
      "year": "2006"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-09-0851",
      "author": "J Mouchawar",
      "doi-asserted-by": "crossref",
      "first-page": "4795",
      "journal-title": "Cancer Res",
      "key": "2_CR17",
      "unstructured": "Mouchawar J, Korch C, Byers T, Pitts TM, Li E, McCredie MR, Giles GG, Hopper JL, Southey MC (2010) Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study. Cancer Res 70:4795–4800",
      "volume": "70",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10689-009-9287-z",
      "author": "OM Ginsburg",
      "doi-asserted-by": "crossref",
      "first-page": "563e7",
      "journal-title": "Fam Cancer",
      "key": "2_CR18",
      "unstructured": "Ginsburg OM, Akbari MR, Aziz Z, Young R, Lynch H, Ghadirian P, Robidoux A, Londono J, Vasquez G, Gomes M, Costa MM, Dimitrakakis C, Gutierrez G, Pilarski R, Royer R, Narod SA (2009) The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30. Fam Cancer 8:563e7",
      "volume": "8",
      "year": "2009"
    },
    {
      "author": "AL Borresen",
      "first-page": "3234e6",
      "journal-title": "Cancer Res",
      "key": "2_CR19",
      "unstructured": "Borresen AL, Andersen TI, Garber J, Barbier-Piraux N, Thorlacius S, Eyfjord J, Ottestad L, Smith-Sorensen B, Hovig E, Malkin D, et al (1992). Screening for germ line TP53 mutations in breast cancer patients. Cancer Res 52:3234e6",
      "volume": "52",
      "year": "1992"
    },
    {
      "author": "C Coles",
      "first-page": "5291e8",
      "journal-title": "Cancer Res",
      "key": "2_CR20",
      "unstructured": "Coles C, Condie A, Chetty U, Steel CM, Evans HJ, Prosser J. (1992) p53 mutations in breast cancer. Cancer Res 52:5291e8",
      "volume": "52",
      "year": "1992"
    },
    {
      "author": "D Sidransky",
      "first-page": "2984e6",
      "journal-title": "Cancer Research",
      "key": "2_CR21",
      "unstructured": "Sidransky D, Tokino T, Helzlsouer K, Zehnbauer B, Rausch G, Shelton B, Prestigiacomo L, Vogelstein B, Davidson N (1992) Inherited p53 gene mutations in breast cancer. Cancer Research 52:2984e6",
      "volume": "52",
      "year": "1992"
    },
    {
      "DOI": "10.1136/jmg.2009.073429",
      "author": "MWG Ruijis",
      "doi-asserted-by": "crossref",
      "first-page": "421",
      "journal-title": "J Med Genet",
      "key": "2_CR22",
      "unstructured": "Ruijis MWG, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst F, Kluijt I, Sijmons RH, Aalfs CM, Wagner A, Ausems M, Hoogerbrugge N, van Asperen CJ, Gomez Garcia E, Meijers-Heijboer H, ten Kate LP, Menko FH, van’t Veer LJ (2010) TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. J Med Genet 47:421–428",
      "volume": "47",
      "year": "2010"
    },
    {
      "DOI": "10.1053/j.gastro.2005.10.014",
      "author": "P Wong",
      "doi-asserted-by": "crossref",
      "first-page": "73",
      "journal-title": "Gastroenterology",
      "key": "2_CR23",
      "unstructured": "Wong P, Verselis SJ, Garber JE, Schneider K, DiGianni L, Stockwell DH, Li FP, Syngal S (2006) Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology 130:73–79",
      "volume": "130",
      "year": "2006"
    },
    {
      "DOI": "10.1007/s10549-012-1993-9",
      "author": "S Masciari",
      "doi-asserted-by": "crossref",
      "first-page": "2984",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "2_CR24",
      "unstructured": "Masciari S, Dillon DA, Rath M et al (2012) Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort. Breast Cancer Res Treat 133(3):2984–2986",
      "volume": "133",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10549-012-2375-z",
      "author": "MG Rath",
      "doi-asserted-by": "crossref",
      "first-page": "193",
      "journal-title": "Breast Cancer Res Treat",
      "key": "2_CR25",
      "unstructured": "Rath MG, Masciari S, Gelman R, Miron A, Miron P, Foley K, Richardson AL, Krop IE, Verselis SJ, Dillon DA, Garber JE (2013) Prevalence of germline TP53 mutations in HER2+ breast cancer patients. Breast Cancer Res Treat 139:193–198.",
      "volume": "139",
      "year": "2013"
    },
    {
      "DOI": "10.1002/cncr.26377",
      "author": "A Melhem-Bertrandt",
      "doi-asserted-by": "crossref",
      "first-page": "908",
      "issue": "4",
      "journal-title": "Cancer",
      "key": "2_CR26",
      "unstructured": "Melhem-Bertrandt A, Bojadzieva J, Ready KJ et al (2012) Early onset HER2-positive breast cancer is associated with germline TP53 mutations. Cancer 118(4):908–913",
      "volume": "118",
      "year": "2012"
    },
    {
      "DOI": "10.1186/1471-2407-12-237",
      "author": "AG Silva",
      "doi-asserted-by": "crossref",
      "first-page": "237",
      "journal-title": "BMC Cancer",
      "key": "2_CR27",
      "unstructured": "Silva AG, Ewald IP, Sapienza M, Pinheiro M, Peixoto A, de Nobrega AF, Carraro DM, Teixeira MR, Ashton-Prolla P, Achatz MI, Rosenberg C, Krepischi AC (2012) Li-Fraumeni-like syndrome associated with a large BRCA1 intragenic deletion. BMC Cancer 12:237",
      "volume": "12",
      "year": "2012"
    },
    {
      "DOI": "10.1200/JCO.2012.46.9403",
      "author": "SM Domchek",
      "doi-asserted-by": "crossref",
      "first-page": "1267",
      "journal-title": "J Clin Oncol",
      "key": "2_CR28",
      "unstructured": "Domchek SM, Bradbury A, Garber JE, Offit K, Robson ME (2013) Multiplex genetic testing for cancer susceptibility: out on the high wire without a net? J Clin Oncol 31:1267–1270",
      "volume": "31",
      "year": "2013"
    },
    {
      "DOI": "10.1002/pon.1352",
      "author": "SK Peterson",
      "doi-asserted-by": "crossref",
      "first-page": "783",
      "issue": "8",
      "journal-title": "Psychooncology",
      "key": "2_CR29",
      "unstructured": "Peterson SK, Pentz RD, Marani SK et al (2008) Psychological functioning in persons considering genetic counseling and testing for Li-Fraumeni syndrome. Psychooncology 17(8):783–789",
      "volume": "17",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2009.27.2112",
      "author": "CR Lammens",
      "doi-asserted-by": "crossref",
      "first-page": "3008",
      "issue": "18",
      "journal-title": "J Clin Oncol",
      "key": "2_CR30",
      "unstructured": "Lammens CR, Aaronson NK, Wagner A et al (2010) Genetic testing in Li-Fraumeni syndrome: uptake and psychosocial consequences. J Clin Oncol 28(18):3008–3014",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1002/pon.1951",
      "author": "CR Lammens",
      "doi-asserted-by": "crossref",
      "first-page": "631",
      "issue": "6",
      "journal-title": "Psychooncology",
      "key": "2_CR31",
      "unstructured": "Lammens CR, Bleiker EM, Verhoef S et al (2011) Distress in partners of individuals diagnosed with or at high risk of developing tumors due to rare hereditary cancer syndromes. Psychooncology 20(6):631–638",
      "volume": "20",
      "year": "2011"
    },
    {
      "DOI": "10.1001/jama.299.11.1315",
      "author": "S Masciari",
      "doi-asserted-by": "crossref",
      "first-page": "1315",
      "journal-title": "JAMA",
      "key": "2_CR32",
      "unstructured": "Masciari S, Van den Abbeele AD, Diller LR, Rastarhuyeva I, Yap J, Schneider K, Digianni L, Li FP, Fraumeni JF Jr, Syngal S, Garber JE (2008) F18-fluorodeoxyglucosepositron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA 299:1315–1319",
      "volume": "299",
      "year": "2008"
    },
    {
      "DOI": "10.1016/S1470-2045(11)70119-X",
      "author": "A Villani",
      "doi-asserted-by": "crossref",
      "first-page": "559",
      "issue": "6",
      "journal-title": "Lancet Oncol",
      "key": "2_CR33",
      "unstructured": "Villani A, Tabori U, Schiffman J et al (2011) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol 12(6):559–567",
      "volume": "12",
      "year": "2011"
    }
  ],
  "reference-count": 33,
  "references-count": 33,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-017-0002-1"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Next generation sequencing is informing phenotype: a TP53 example"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}